...
首页> 外文期刊>Open medicine >Diagnosis of complication in lung transplantation by TBLB ROSE mNGS
【24h】

Diagnosis of complication in lung transplantation by TBLB ROSE mNGS

机译:TBLB Rose Mngs诊断肺移植并发症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Lung transplantation is a potentially life-saving therapy for patients with terminal respiratory illnesses. Long-term survival is limited by the development of a variety of opportunistic infections and rejection. Optimal means of differential diagnosis of infection and rejection have not been established. With these challenges in mind, we tried to use transbronchial lung biopsy (TBLB) rapid on-site cytological evaluation (ROSE), metagenomic next-generation sequencing (mNGS), and routine histologic examination to timely distinguish infection and rejection, and accurately detect etiologic pathogens. We reviewed the medical records of all patients diagnosed with infection or rejection by these means from December 2017 to September 2018 in our center. We identified seven recipients whose clinical course was complicated by infection or rejection. Three patients were diagnosed with acute rejection, organizing pneumonia, and acute fibrinoid organizing pneumonia, respectively. Four of the seven patients were diagnosed with infections, including Pneumocystis carinii pneumonia, cytomegalovirus, Aspergillus , and bacterial pneumonia. These patients recovered after proper treatment. TBLB ROSE mNGS might be a good method to accurately detect etiologic pathogens, which may help us to facilitate the use of targeted and precision medicine therapy in postoperative complications and avoid unnecessary potential adverse effects of drugs.
机译:肺移植是终末呼吸疾病患者的潜在救生疗法。长期存活受到各种机会主义感染和拒绝的影响。尚未建立鉴别诊断的最佳手段和拒绝。在这些挑战中,我们试图使用跨界肺活检(TBLB)快速现场细胞学评估(玫瑰),梅毒下一代测序(MNGs),以及常规的组织学检查,及时区分感染和排斥,并准确检测病因病原体。我们在2017年12月至2018年9月,我们在2017年12月至2018年9月,我们审查了所有患者的病历。我们鉴定了七个受体,其临床过程通过感染或排斥而复杂化。患有急性排斥,组织肺炎和急性纤维蛋白组组织肺炎的三名患者。七名患者中有四名患者被诊断出患有感染,包括肺细胞肺炎肠道肺炎,巨细胞病毒,曲霉和细菌肺炎。这些患者在适当的治疗后恢复。 TBLB Rose Mngs可能是准确检测病因病原体的好方法,这可能有助于我们在术后并发症中促进使用有针对性和精密药物治疗,并避免药物的不必要的潜在不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号